| Recent CGEM Stock Price | CGEM Stock Predictions | |
| $8.77 | ![]() +199.32% |
$26.25 |
| Recent CGEM Analyst Ratings Breakdown, Making CGEM Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 10 | 10 | 10 | 9 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 1 | 1 |
| Average rating: | 1.18 | 1.18 | 1.36 | 1.4 |
For the CGEM stock predictions from the analysts covering Cullinan Therapeutics Inc, we have collected all of the individual CGEM stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering CGEM (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CGEM stock predictions may vary widely, another useful metric to consider is the median CGEM stock prediction, which represents the price at which half of the analysts
made CGEM stock predictions that were higher and half made CGEM stock predictions that were lower. This makes for a different take on the CGEM stock predictions out there, as compared to average or mean.
And that median across all the individual CGEM stock predictions was: $24.5 as of 2025-11-14.
The very highest of the CGEM stock predictions for one year price target was $34.0, while the very lowest of the CGEM stock predictions in the analyst group was
$21.0 (with a standard deviation of $4.682). Get the latest Zacks research report on CGEM — FREE
Find out: CGEM next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
TESS Stock Predictions
PM Stock Predictions
IMMR Stock Predictions
HURN Stock Predictions
REKR Stock Predictions
RDI Stock Predictions
MHK Stock Predictions
BFIN Stock Predictions
KINS Stock Predictions
|
|||||||||
Strong Buy (3.82 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |